1044  IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3.

1043  Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation.

1042  Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.

1041  Transfer of strain-specific antibodies after bone marrow transplant prevents cytomelagovirus reactivation in the recipient.

1040  Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases.

1039  Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin.

1038  Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy,

1037  Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells.

1036  Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice.

1035  FGL1 is identified as a major ligand for the inhibitory receptor LAG-3, and its blockade can potentiate anti-tumor T cell responses.

Free Images for Presentation: sunipix SUNIPIX